Characteristics of p210BCR/ABL/BHX2 mice with lymphoid leukemias
| Mouse no. . | Age at disease, mo . | PB parameters . | Macroscopic tumor sites . | Surface markers . | Diagnosis . | ||
|---|---|---|---|---|---|---|---|
| WBC, ×109/L . | Hb, g/L . | Plt, ×109/L . | |||||
| 30 | 2.6 | 11.2 (blast ∼ 70%) | 140 | 452 | Spl, LN | Thy1.2−, CD19+, Gr.1−, Mac1− | B-cell leukemia |
| 1 | 3.0 | 10.0 (blast ∼ 60%) | 124 | 238 | Thy, Spl | Thy1.2+, CD19−, Gr.1−, Mac1− | T-cell leukemia |
| 17 | 4.2 | 82.4 (blast ∼ 100%) | 109 | 525 | Spl, LN | Thy1.2+, CD19−, Gr.1−, Mac1− | B-cell leukemia |
| 5 | 4.8 | 22.0 (blast ∼ 100%) | 123 | 339 | Thy, Spl, LN | Thy1.2−, CD19+, Gr.1−, Mac1− | T-cell leukemia |
| 18 | 5.2 | 68.0 (blast ∼ 100%) | 118 | 345 | Spl, LN | Thy1.2−, CD19+, Gr.1−, Mac1− | B-cell leukemia |
| 23 | 5.4 | 19.8 (blast ∼ 100%) | 107 | 338 | Spl, LN | Thy1.2−, CD19+, Gr.1−, Mac1− | B-cell leukemia |
| Mouse no. . | Age at disease, mo . | PB parameters . | Macroscopic tumor sites . | Surface markers . | Diagnosis . | ||
|---|---|---|---|---|---|---|---|
| WBC, ×109/L . | Hb, g/L . | Plt, ×109/L . | |||||
| 30 | 2.6 | 11.2 (blast ∼ 70%) | 140 | 452 | Spl, LN | Thy1.2−, CD19+, Gr.1−, Mac1− | B-cell leukemia |
| 1 | 3.0 | 10.0 (blast ∼ 60%) | 124 | 238 | Thy, Spl | Thy1.2+, CD19−, Gr.1−, Mac1− | T-cell leukemia |
| 17 | 4.2 | 82.4 (blast ∼ 100%) | 109 | 525 | Spl, LN | Thy1.2+, CD19−, Gr.1−, Mac1− | B-cell leukemia |
| 5 | 4.8 | 22.0 (blast ∼ 100%) | 123 | 339 | Thy, Spl, LN | Thy1.2−, CD19+, Gr.1−, Mac1− | T-cell leukemia |
| 18 | 5.2 | 68.0 (blast ∼ 100%) | 118 | 345 | Spl, LN | Thy1.2−, CD19+, Gr.1−, Mac1− | B-cell leukemia |
| 23 | 5.4 | 19.8 (blast ∼ 100%) | 107 | 338 | Spl, LN | Thy1.2−, CD19+, Gr.1−, Mac1− | B-cell leukemia |
Spl indicates spleen; LN, lymph node; and Thy, thymus.